Personnel Today
  • Home
    • All PT content
  • Email sign-up
  • Topics
    • HR Practice
    • Employee relations
    • Learning & training
    • Pay & benefits
    • Recruitment & retention
    • Wellbeing
    • Occupational Health
    • HR strategy
    • HR Tech
    • The HR profession
    • Global
    • All HR topics
  • Legal
    • Case law
    • Commentary
    • Flexible working
    • Legal timetable
    • Maternity & paternity
    • Shared parental leave
    • Redundancy
    • TUPE
    • Disciplinary and grievances
    • Employer’s guides
  • AWARDS
    • Personnel Today Awards
    • The RAD Awards
  • Jobs
    • Find a job
    • Jobs by email
    • Careers advice
    • Post a job
  • Brightmine
    • Learn more
    • Products
    • Free trial
    • Request a quote
  • Webinars
  • Advertise

Personnel Today

Register
Log in
Personnel Today
  • Home
    • All PT content
  • Email sign-up
  • Topics
    • HR Practice
    • Employee relations
    • Learning & training
    • Pay & benefits
    • Recruitment & retention
    • Wellbeing
    • Occupational Health
    • HR strategy
    • HR Tech
    • The HR profession
    • Global
    • All HR topics
  • Legal
    • Case law
    • Commentary
    • Flexible working
    • Legal timetable
    • Maternity & paternity
    • Shared parental leave
    • Redundancy
    • TUPE
    • Disciplinary and grievances
    • Employer’s guides
  • AWARDS
    • Personnel Today Awards
    • The RAD Awards
  • Jobs
    • Find a job
    • Jobs by email
    • Careers advice
    • Post a job
  • Brightmine
    • Learn more
    • Products
    • Free trial
    • Request a quote
  • Webinars
  • Advertise

Latest NewsPay & benefitsHealth insurance

Herceptin launch could push up cost of private medical insurance for employers

by dan thomas 22 Jun 2006
by dan thomas 22 Jun 2006

Employers that provide private medical insurance for their staff may need to prepare for increased costs from next month as Herceptin – a drug being used to treat early breast cancer – is launched, according to experts.

In July, the National Institute of Clinical Excellence will complete its licensing of Herceptin for use within the NHS and, as a result, most insurers are expected to extend their cover to include this drug treatment, unless specific exclusions are made.

Consequently, private healthcare costs will increase by up to £35,000 for each employee who is treated, according to Mercer Human Resource Consulting.

“The news that Herceptin will be covered under the NHS will be a welcome development for many cancer sufferers,” said Stephen Clements, principal at Mercer.

“While some private medical insurers currently cover Herceptin treatment, the majority are expected to follow suit with the NHS and extend their policies from next month.

“Employers may then find themselves having to choose between accepting the change, requesting a specific exclusion or choosing a different, more restricted plan option,” he added.

As well as emotive pressures, employers could face potential discrimination claims if they specifically exclude Herceptin treatment from their plans, so few will feel in a position to do so, Clements said.

“Even though the drug will be available through the NHS, it will be difficult to justify not covering it in a private plan without making alternative provisions, when other, less serious illnesses are included and when short waiting times are crucial,” he said.

Depending on the make-up of their workforce, some companies could see higher than average cost increases and so should budget accordingly, Clements advised.

However, worries that company medical insurance premiums could rocket following the approval of Herceptin are largely unfounded, according to a medical expert.

Sign up to our weekly round-up of HR news and guidance

Receive the Personnel Today Direct e-newsletter every Wednesday

OptOut
This field is for validation purposes and should be left unchanged.

Nicky Crystal, who specialises in corporate healthcare at SPS Wellbeing, said concerns over premium rises had been “over-hyped”. She said a combination of factors would limit the impact of claims in the corporate sector.

“Many sufferers of breast cancer are over 50, which means fewer staff are likely to need the treatment,” Crystal said. “Also, there are unlikely to be many claims in total, and corporate premiums are based on claims history and not the total number of claims made across the market.

dan thomas

previous post
Working parents to benefit from new rights as Work and Families Bill receives Royal Assent
next post
Asda claims five-day strike by GMB members will not hurt business

You may also like

Decision to sack man for Michael Jackson noises...

29 Aug 2025

P&O Ferries boss who steered 800 sackings steps...

29 Aug 2025

UK large companies’ succession planning is weak –...

29 Aug 2025

Gender bonus bias widens pay gap, says Brightmine

29 Aug 2025

Bankers learn of redundancy in email gaffe asking...

29 Aug 2025

Cabin crew manager with ‘flirty banter’ loses discrimination...

29 Aug 2025

Council clerk sacked after trying to ensure his...

29 Aug 2025

Four-day working week trial in Scotland’s public sector...

29 Aug 2025

Day one rights in the Employment Rights Bill...

28 Aug 2025

EHRC acts on policies flouting law on single-sex...

28 Aug 2025

  • Work smart – stay well: Avoid unnecessary pain with centred ergonomics SPONSORED | If you often notice...Read more
  • Elevate your L&D strategy at the World of Learning 2025 SPONSORED | This October...Read more
  • How to employ a global workforce from the UK (webinar) WEBINAR | With an unpredictable...Read more

Personnel Today Jobs
 

Search Jobs

PERSONNEL TODAY

About us
Contact us
Browse all HR topics
Email newsletters
Content feeds
Cookies policy
Privacy policy
Terms and conditions

JOBS

Personnel Today Jobs
Post a job
Why advertise with us?

EVENTS & PRODUCTS

The Personnel Today Awards
The RAD Awards
Employee Benefits
Forum for Expatriate Management
Whatmedia

ADVERTISING & PR

Advertising opportunities
Features list 2025

  • Facebook
  • Twitter
  • Instagram
  • Linkedin


© 2011 - 2025 DVV Media International Ltd

Personnel Today
  • Home
    • All PT content
  • Email sign-up
  • Topics
    • HR Practice
    • Employee relations
    • Learning & training
    • Pay & benefits
    • Recruitment & retention
    • Wellbeing
    • Occupational Health
    • HR strategy
    • HR Tech
    • The HR profession
    • Global
    • All HR topics
  • Legal
    • Case law
    • Commentary
    • Flexible working
    • Legal timetable
    • Maternity & paternity
    • Shared parental leave
    • Redundancy
    • TUPE
    • Disciplinary and grievances
    • Employer’s guides
  • AWARDS
    • Personnel Today Awards
    • The RAD Awards
  • Jobs
    • Find a job
    • Jobs by email
    • Careers advice
    • Post a job
  • Brightmine
    • Learn more
    • Products
    • Free trial
    • Request a quote
  • Webinars
  • Advertise